Journal
CELL STEM CELL
Volume 5, Issue 6, Pages 584-595Publisher
CELL PRESS
DOI: 10.1016/j.stem.2009.11.009
Keywords
-
Categories
Funding
- NIH [RO1-HDO45022, R37-CA084198, RO1-CA087869]
- Society in Science: The Branco-Weiss
Ask authors/readers for more resources
Reprogramming of human somatic cells uses readily accessible tissue, such as skin or blood, to generate embryonic-like induced pluripotent stem cells (iPSCs). This procedure has been applied to somatic cells from patients who are classified into a disease group, thus creating disease-specific iPSCs. Here, we examine the challenges and assumptions in creating a disease model from a single cell of the patient. Both the kinetics of disease onset and progression as well as the spatial localization of disease in the patient's body are challenges to disease modeling. New tools in genetic modification, reprogramming, biomaterials, and animal models can be used for addressing these challenges.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available